Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_30140 | 22 | 0.46 | Mlig455_055220 | Neo: - Age: - |
GALR2 | Mlig455_055220 {REF} {Length: 2272} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.2]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=21.8]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [RH, Score=167, Expect=4e-47]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [RH, Score=164, Expect=2e-46]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [RH, Score=133, Expect=8e-34]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=115, Expect=2e-28]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=142, Expect=6e-38]} {RNA1310_26096} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.98 | 0.955 | 0.99961 | 1.00000 | |
RegionR2 | 3.468 | 0.955 | 0.19117 | 0.54710 | |
RegionR3 | 0.087 | 0.955 | 0.99977 | 1.00000 | |
RegionR4 | 0.804 | 0.955 | 0.11351 | 0.33423 | |
RegionR5 | -0.09 | 0.955 | 0.99973 | 1.00000 | |
RegionR6 | -1.32 | 0.955 | 0.99975 | 1.00000 | |
RegionR7 | -1.318 | 0.955 | 0.99982 | 1.00000 | |
RegionR8 | -0.651 | 0.955 | 0.99973 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.743 | 0.955 | 0.99999 | 1.00000 | |
RegenerationR2 | -0.625 | 0.955 | 0.23790 | 0.68597 | |
RegenerationR3 | 0.911 | 0.955 | 0.25564 | 0.68991 | |
RegenerationR4 | -0.585 | 0.955 | 0.88210 | 1.00000 | |
RegenerationR5 | 0.053 | 0.955 | 0.36830 | 0.77898 | |
RegenerationR6 | 2.195 | 0.955 | 0.16815 | 0.49876 | |
RegenerationBL | -1.665 | 0.955 | 0.99990 | 1.00000 | |
RegenerationTP | -1.101 | 0.955 | 0.99994 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_30140 | 22 | 0.46 | Mlig455_055220 | Neo: - Age: - |
GALR2 | 3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_055220 {REF} {Length: 2272} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.2]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=21.8]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [RH, Score=167, Expect=4e-47]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [RH, Score=164, Expect=2e-46]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [RH, Score=133, Expect=8e-34]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=115, Expect=2e-28]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=142, Expect=6e-38]} {RNA1310_26096} |
2. | MligTC455_15229 | 6 | 0.12 | Mlig455_032752 | Neo: - Age: - |
2.785 | - | - | 0.957 | 0.916 | 0.912 | - | Mlig455_032752 {REF} {Length: 1841} {Pfam: F5/8 type C domain [PF00754.27, score=51.0]; PAN-like domain [PF08277.14, score=26.2]} {Smed: dd_Smed_v6_1477_1_1, dd_Smed_v6_1477_1_1, [RH, Score=51.2, Expect=6e-08]} {RNA1509_36923} {RNA1310_46041} {RNA815_10591.1} | |
3. | MligTC455_13926 | 38 | 0.8 | Mlig455_025264 | Neo: - Age: Up-Down-Down |
KIF1B | 2.758 | - | - | 0.857 | 0.976 | 0.925 | - | Mlig455_025264 {REF} {Length: 4693} {Pfam: Kinesin motor domain [PF00225.25, score=344.2]; Microtubule binding [PF16796.7, score=68.5]; FHA domain [PF00498.28, score=31.2]; Kinesin-associated [PF16183.7, score=28.8]} {Human: ENSG00000054523, KIF1B, kinesin family member 1B, [Score=464, Expect=2e-150]; ENSG00000130294, KIF1A, kinesin family member 1A, [Score=447, Expect=2e-140]; ENSG00000129250, KIF1C, kinesin family member 1C, [Score=446, Expect=7e-144]} {Mouse: ENSMUSG00000087236, Kif28, kinesin family member 28, [Score=499, Expect=4e-165]} {Dmel: FBgn0019968, Khc-73, Kinesin heavy chain 73, [Score=439, Expect=7e-137]} {Celegans: WBGene00002218, klp-6, Kinesin-like protein, [Score=560, Expect=0.0]} {Smed: dd_Smed_v6_12573_0_1, dd_Smed_v6_12573_0_1, [Score=640, Expect=0.0]} {RNA1509_18998} {RNA1310_9866} {RNA815_31497} |
4. | MligTC455_40051 | 36 | 0.76 | Mlig455_025990 | Neo: - Age: logFC(26M/2M)=-0.633 |
PRKCE | 2.712 | - | - | 0.840 | 0.961 | 0.911 | - | Mlig455_025990 {REF} {Length: 2622} {Pfam: Protein kinase domain [PF00069.27, score=102.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.5]; Kinase-like [PF14531.8, score=19.5]} {Human: ENSG00000171132, PRKCE, protein kinase C epsilon, [Score=84.3, Expect=1e-16]} {Mouse: ENSMUSG00000045038, Prkce, protein kinase C, epsilon, [Score=82.0, Expect=5e-16]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=79.0, Expect=2e-15]} {Celegans: WBGene00009793, pkn-1, Protein Kinase N (PKN) homolog, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_8010_0_1, dd_Smed_v6_8010_0_1, [Score=77.8, Expect=4e-15]} {RNA1509_36146} {RNA1310_24732} {RNA815_64704} |
5. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
2.637 | - | - | 0.790 | 0.887 | 0.960 | - | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
6. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 2.632 | - | - | 0.963 | 0.781 | 0.888 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
7. | MligTC455_17089 | 173 | 3.6 | Mlig455_022974 | Neo: - Age: - Region-enriched R4: 2.568/0.01700 |
2.604 | - | - | 0.773 | 0.852 | 0.979 | - | Mlig455_022974 {REF} {Length: 1697} {RNA1509_56619} {RNA1310_21133.1} {RNA815_8631.1} | |
8. | MligTC455_35365 | 14 | 0.29 | Mlig455_051974 | Neo: - Age: - |
NPFFR2 | 2.603 | - | - | 0.743 | 0.971 | 0.889 | - | Mlig455_051974 {REF} {Length: 1412} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=184.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=44.6]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=172, Expect=6e-49]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=162, Expect=3e-45]; ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=155, Expect=7e-43]} {Dmel: FBgn0004842, RYa-R, RYamide receptor, [Score=168, Expect=3e-47]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [RH, Score=157, Expect=9e-44]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=265, Expect=5e-85]} {RNA1310_123208} {RNA815_46307} |
9. | MligTC455_23977 | 63 | 1.31 | Mlig455_012689 | Neo: - Age: - Regeneration-downregulated R5: -6.245 Regeneration-depleted R5: -6.245 |
DRD2 | 2.522 | - | - | 0.753 | 0.788 | 0.981 | - | Mlig455_012689 {REF} {Length: 2124} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=191.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.4]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=168, Expect=4e-46]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=160, Expect=4e-43]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=159, Expect=2e-42]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=198, Expect=7e-57]} {RNA1310_28840} {RNA815_30584} |
10. | MligTC455_49557 | 280 | 5.82 | Mlig455_017273 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.728 Region-specific R2: 3.642 Region-enriched R2: 3.187/0.00196 |
2.46 | - | - | 0.705 | 0.805 | 0.950 | - | Mlig455_017273 {REF} {Length: 1333} {RNA1509_52848} {RNA1310_64923, RNA1509_52848} {RNA1509_52848, RNA815_51063} | |
11. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 1.945 | - | - | 0.964 | - | 0.981 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
12. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
1.943 | - | - | 0.982 | - | 0.961 | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
13. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
1.939 | - | - | 0.994 | - | 0.945 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
14. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
1.932 | - | - | 0.979 | - | 0.953 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
15. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 1.929 | - | - | 0.975 | - | 0.954 | - | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
16. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 1.926 | - | - | 0.974 | - | 0.952 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
17. | MligTC455_50837 | 14 | 0.29 | Mlig455_013450 | Neo: - Age: - |
PLSCR5 | 1.925 | - | - | 0.988 | - | 0.937 | - | Mlig455_013450 {REF} {Length: 1455} {Pfam: Scramblase [PF03803.17, score=121.2]} {Human: ENSG00000231213, PLSCR5, phospholipid scramblase family member 5, [Score=102, Expect=2e-24]; ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000095654, Plscr5, phospholipid scramblase family, member 5, [Score=102, Expect=1e-24]; ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=97.8, Expect=2e-22]} {Dmel: FBgn0035390, scramb2, scramblase 2, [Score=87.8, Expect=2e-19]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=102, Expect=9e-25]} {Smed: dd_Smed_v6_4312_0_2, dd_Smed_v6_4312_0_2, [Score=92.4, Expect=1e-21]} {RNA1310_119369} |
18. | MligTC455_25414 | 32 | 0.66 | Mlig455_000371 | Neo: - |
TRPM3 | 1.923 | - | - | 0.969 | - | 0.954 | - | Mlig455_000371 {REF} {Length: 4372} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=75.7]; Ankyrin repeats (many copies) [PF13637.8, score=64.1]; Ankyrin repeat [PF13606.8, score=39.6]; Ankyrin repeats (many copies) [PF13857.8, score=31.8]; Ankyrin repeat [PF00023.32, score=27.0]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=80.1, Expect=2e-14]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=79.3, Expect=3e-14]; ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=76.6, Expect=2e-13]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=64.7, Expect=4e-10]} {Smed: dd_Smed_v6_26251_0_1, dd_Smed_v6_26251_0_1, [Score=79.3, Expect=8e-15]} {RNA1509_18305} {RNA1310_1324.1} {RNA815_16630} |
19. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
1.921 | - | - | 0.962 | - | 0.959 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
20. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
1.916 | - | - | 0.968 | - | 0.948 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
21. | MligTC455_36698 | 41 | 0.85 | Mlig455_020379, Mlig455_020438 | Neo: - Age: - Region-enriched R4: 4.050/0.03458 |
1.916 | - | - | 0.991 | - | 0.925 | - | Mlig455_020379 {REF} {Length: 1748} {Celegans: WBGene00007723, C25F9.2, [Score=77.8, Expect=7e-17]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} Mlig455_020438 {REF} {Length: 2872} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=53.1]} {Celegans: WBGene00007723, C25F9.2, [Score=206, Expect=7e-57]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} |
|
22. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
1.912 | - | - | 0.998 | - | 0.914 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
23. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 1.912 | - | - | 0.973 | - | 0.939 | - | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
24. | MligTC455_41226 | 44 | 0.92 | Mlig455_019357, Mlig455_059122 | Neo: - Age: - |
GALNT1 | 1.91 | - | - | 0.973 | - | 0.937 | - | Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943} Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943} |
25. | MligTC455_53838 | 10 | 0.21 | Mlig455_008156 | Neo: - Age: - |
1.91 | - | - | 0.998 | - | 0.912 | - | Mlig455_008156 {REF} {Length: 2378} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=7e-08]} {RNA1310_37888} {RNA815_29107} | |
26. | MligTC455_13563 | 29 | 0.6 | Mlig455_057359, Mlig455_059570 | Neo: - Age: - |
1.908 | - | - | 0.969 | - | 0.939 | - | Mlig455_057359 {REF} {Length: 700} {NoTransDecoderORF} {RNA1310_89069} {RNA815_57947} Mlig455_059570 {REF} {Length: 395} {NoTransDecoderORF} {RNA1310_89069} {RNA815_57947} |
|
27. | MligTC455_10151 | 146 | 3.05 | Mlig455_068692, Mlig455_068719 | Neo: - Age: - |
KREMEN1 | 1.907 | - | - | 0.994 | - | 0.913 | - | Mlig455_068692 {REF} {Length: 1086} {Pfam: WSC domain [PF01822.21, score=56.5]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.4, Expect=7e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=68.9, Expect=2e-14]} {RNA1310_42686} {RNA815_25047} Mlig455_068719 {REF} {Length: 1973} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=55.8]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.1, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=67.0, Expect=8e-14]} {RNA1509_56630} {RNA1310_42686} {RNA815_25047} |
28. | MligTC455_19097 | 120 | 2.49 | Mlig455_035179 | Neo: - Age: - Region-enriched R2: 5.873/0.00339 |
KCNK3 | 1.906 | - | - | 0.984 | - | 0.922 | - | Mlig455_035179 {REF} {Length: 2899} {Pfam: Ion channel [PF07885.18, score=103.1]; Ion transport protein [PF00520.33, score=23.8]} {Human: ENSG00000171303, KCNK3, potassium two pore domain channel subfamily K member 3, [Score=67.0, Expect=5e-11]; ENSG00000169427, KCNK9, potassium two pore domain channel subfamily K member 9, [Score=65.9, Expect=1e-10]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]} {Dmel: FBgn0033257, sand, sandman, [Score=105, Expect=4e-24]} {Celegans: WBGene00006690, twk-39, TWiK family of potassium channels, [RH, Score=117, Expect=4e-27]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=188, Expect=7e-51]} {RNA1310_31604} {RNA815_54785} |
29. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.903 | - | - | 0.975 | - | 0.928 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
30. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 1.903 | - | - | 0.963 | - | 0.940 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
31. | MligTC455_51759 | 40 | 0.83 | Mlig455_026782 | Neo: - Age: - Region-enriched R4: 4.435/0.02831 |
CNBD2 | 1.901 | - | - | 0.973 | - | 0.928 | - | Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620} |
32. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 1.901 | - | - | 0.945 | - | 0.956 | - | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
33. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
1.9 | - | - | 0.962 | - | 0.938 | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
34. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
1.9 | - | - | 0.965 | - | 0.935 | - | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
35. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.9 | - | - | 0.981 | - | 0.919 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
36. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
1.898 | - | - | 0.953 | - | 0.945 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
37. | MligTC455_15837 | 58 | 1.21 | Mlig455_058574 | Neo: - Age: Up-Down-Up |
PLEKHG5 | 1.897 | - | - | 0.933 | - | 0.964 | - | Mlig455_058574 {REF} {Length: 3473} {Pfam: RhoGEF domain [PF00621.22, score=89.0]; Pleckstrin homology domain [PF15405.8, score=20.1]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=191, Expect=1e-49]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=194, Expect=1e-50]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=1e-35]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=142, Expect=3e-34]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [Score=171, Expect=2e-44]} {RNA1310_47096} {RNA815_12538} |
38. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.897 | - | - | 0.955 | - | 0.942 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
39. | MligTC455_16844 | 22 | 0.47 | Mlig455_032383 | Neo: - Age: - |
NPY1R | 1.896 | - | - | 0.950 | - | 0.946 | - | Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955} |
40. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
1.896 | - | - | 0.956 | - | 0.940 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
41. | MligTC455_41988 | 81 | 1.68 | Mlig455_049279, Mlig455_050624 | Neo: - Age: - |
1.894 | - | - | 0.938 | - | 0.956 | - | Mlig455_049279 {REF} {Length: 6361} {Pfam: Innexin [PF00876.20, score=408.1]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=1e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=341, Expect=5e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=483, Expect=3e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_25566} Mlig455_050624 {REF} {Length: 2845} {Pfam: Innexin [PF00876.20, score=408.0]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=2e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=342, Expect=3e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=484, Expect=1e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_1848.2} |
|
42. | MligTC455_19567 | 76 | 1.59 | Mlig455_017855, Mlig455_047877 | Neo: - Age: - Region-enriched R2: 7.793/0.00005 |
1.891 | - | - | 0.996 | - | 0.895 | - | Mlig455_017855 {REF} {Length: 1874} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.0]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=3e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} Mlig455_047877 {REF} {Length: 1820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.8]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=2e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} |
|
43. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 1.891 | - | - | 0.979 | - | 0.912 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
44. | MligTC455_49492 | 10 | 0.21 | Mlig455_054890 | Neo: - Age: - |
1.891 | - | - | 0.979 | - | 0.912 | - | Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
45. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.89 | - | - | 0.978 | - | 0.912 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
46. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 1.886 | - | - | 0.973 | - | 0.913 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
47. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 1.885 | - | - | 0.973 | - | 0.912 | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
48. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 1.884 | - | - | 0.972 | - | 0.912 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
49. | MligTC455_41724 | 23 | 0.49 | Mlig455_001647 | Neo: - |
1.883 | - | - | 0.955 | - | 0.928 | - | Mlig455_001647 {REF} {Length: 1808} {RNA1310_22665} {RNA815_13308} | |
50. | MligTC455_19526 | 40 | 0.84 | Mlig455_032263 | Neo: - Age: - Region-enriched R5: 4.476/0.00075 |
1.882 | - | - | - | 0.928 | 0.954 | - | Mlig455_032263 {REF} {Length: 986} {RNA1509_59284} {RNA1310_56370} {RNA815_27780} | |
51. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 1.881 | - | - | 0.969 | - | 0.912 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
52. | MligTC455_13072 | 18 | 0.37 | Mlig455_066620 | Neo: - Age: - |
HDC | 1.881 | - | - | 0.991 | - | 0.890 | - | Mlig455_066620 {REF} {Length: 3571} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=359.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=26.2]} {Human: ENSG00000140287, HDC, histidine decarboxylase, [RH, Score=493, Expect=1e-167]} {Mouse: ENSMUSG00000027360, Hdc, histidine decarboxylase, [Score=466, Expect=9e-157]} {Dmel: FBgn0005619, Hdc, Histidine decarboxylase, [Score=516, Expect=5e-177]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=404, Expect=8e-133]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=409, Expect=9e-137]} {RNA1310_91546} |
53. | MligTC455_21227 | 18 | 0.37 | Mlig455_018373 | Neo: - Age: - |
RGS6 | 1.878 | - | - | 0.966 | - | 0.912 | - | Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067} |
54. | MligTC455_07705 | 6 | 0.13 | Mlig455_012841 | Neo: - Age: - |
1.876 | - | - | 0.964 | - | 0.912 | - | Mlig455_012841 {REF} {Length: 1042} {Smed: dd_Smed_v6_38985_0_1, dd_Smed_v6_38985_0_1, [Score=54.3, Expect=9e-09]} {RNA1310_136328} | |
55. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 1.874 | - | - | 0.958 | 0.916 | - | - | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
56. | MligTC455_32326 | 37 | 0.77 | Mlig455_001525 | Neo: - Age: - |
TRIM9 | 1.874 | - | - | 0.980 | - | 0.894 | - | Mlig455_001525 {REF} {Length: 3229} {Pfam: SPRY domain [PF00622.30, score=48.4]; B-box zinc finger [PF00643.26, score=33.5]; zinc finger of C3HC4-type, RING [PF15227.8, score=28.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=28.1]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=25.4]; RING-type zinc-finger [PF13445.8, score=24.0]; Fibronectin type III domain [PF00041.23, score=23.3]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=21.4]; Prokaryotic RING finger family 4 [PF14447.8, score=18.8]} {Human: ENSG00000100505, TRIM9, tripartite motif containing 9, [Score=475, Expect=2e-158]} {Mouse: ENSMUSG00000021071, Trim9, tripartite motif-containing 9, [Score=474, Expect=3e-158]} {Dmel: FBgn0051721, Trim9, Tripartite motif containing 9, [Score=444, Expect=1e-146]} {Celegans: WBGene00016539, madd-2, [Score=409, Expect=1e-132]} {Smed: dd_Smed_v6_8386_0_1, dd_Smed_v6_8386_0_1, [Score=524, Expect=1e-177]} {RNA1509_37451} {RNA1310_8634.1} {RNA815_9833} |
57. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.872 | - | - | 0.916 | - | 0.956 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
58. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
1.868 | - | - | 0.963 | - | 0.905 | - | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
59. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.868 | - | - | 0.953 | - | 0.915 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
60. | MligTC455_52349 | 99 | 2.06 | Mlig455_011056 | Neo: - Age: - |
DGKI | 1.867 | - | - | 0.970 | - | 0.897 | - | Mlig455_011056 {REF} {Length: 3706} {Pfam: Diacylglycerol kinase accessory domain [PF00609.21, score=146.1]; Diacylglycerol kinase catalytic domain [PF00781.26, score=101.1]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=31.0]; Proline-rich protein family 20 [PF15708.7, score=21.0]} {Human: ENSG00000157680, DGKI, diacylglycerol kinase iota, [Score=677, Expect=0.0]; ENSG00000149091, DGKZ, diacylglycerol kinase zeta, [Score=672, Expect=0.0]} {Mouse: ENSMUSG00000038665, Dgki, diacylglycerol kinase, iota, [Score=682, Expect=0.0]; ENSMUSG00000040479, Dgkz, diacylglycerol kinase zeta, [Score=667, Expect=0.0]} {Dmel: FBgn0261549, rdgA, retinal degeneration A, [Score=533, Expect=8e-173]} {Celegans: WBGene00019428, dgk-5, Putative diacylglycerol kinase K06A1.6, [RH, Score=491, Expect=4e-158]} {Smed: dd_Smed_v6_12579_0_4, dd_Smed_v6_12579_0_4, [Score=629, Expect=0.0]} {RNA1509_51540} {RNA1310_9558, RNA1509_51540} {RNA1509_51540, RNA815_11195} |
61. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 1.865 | - | - | 0.950 | - | 0.915 | - | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
62. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.863 | - | - | 0.967 | - | 0.896 | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
63. | MligTC455_35769 | 90 | 1.87 | Mlig455_034140, Mlig455_050376, Mlig455_062180 | Neo: - |
1.861 | - | - | 0.898 | - | 0.963 | - | Mlig455_034140 {REF} {Length: 1714} {RNA1509_25690} {RNA1310_57234} {RNA815_17883} Mlig455_050376 {REF} {Length: 2093} {TRANSSPLICED} {RNA1509_54944} {RNA1310_23258} {RNA815_47172} Mlig455_062180 {REF} {Length: 90} {NoTransDecoderORF} {RNA1509_25690} {RNA1310_65891} {RNA815_17883} |
|
64. | MligTC455_13433 | 11 | 0.22 | Mlig455_025860 | Neo: - Age: - Region-enriched R2: 6.296/0.01497 |
1.856 | - | - | 0.964 | - | 0.892 | - | Mlig455_025860 {REF} {Length: 1640} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.7]} {RNA1310_51631} {RNA815_34338} | |
65. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
1.856 | - | - | 0.975 | - | 0.881 | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
66. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
1.855 | - | - | 0.899 | - | 0.956 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
67. | MligTC455_13434 | 15 | 0.3 | Mlig455_025922 | Neo: - Age: - |
1.853 | - | - | 0.964 | - | 0.889 | - | Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338} | |
68. | MligTC455_43642 | 2199 | 45.81 | Mlig455_018475 | Neo: - Age: Down-Up-Up Region-specific R2: 2.701 Region-enriched R2: 2.110/0.00000 |
1.852 | - | - | 0.901 | - | 0.951 | - | Mlig455_018475 {REF} {Length: 949} {RNA1509_30521} {RNA1310_47277.3, RNA1509_30521} {RNA1509_30521, RNA815_19145.1} | |
69. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
1.851 | - | - | 0.962 | - | 0.889 | - | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
70. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
1.85 | - | - | 0.960 | - | 0.890 | - | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
71. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 1.849 | - | - | 0.891 | - | 0.958 | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
72. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 1.849 | - | - | - | 0.879 | 0.970 | - | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
73. | MligTC455_38047 | 12 | 0.25 | Mlig455_042187, Mlig455_059009 | Neo: - Age: - |
1.849 | - | - | 0.964 | - | 0.885 | - | Mlig455_042187 {REF} {Length: 374} {NoTransDecoderORF} {RNA1509_4618} {RNA1310_17333} {RNA815_9866.2} Mlig455_059009 {REF} {Length: 1388} {Pfam: PAN domain [PF14295.8, score=18.8]} {RNA1509_48973} {RNA1310_27015.1} {RNA815_36286} |
|
74. | MligTC455_40355 | 10 | 0.21 | Mlig455_069630 | Neo: - Age: - |
KREMEN1 | 1.849 | - | - | 0.956 | 0.893 | - | - | Mlig455_069630 {REF} {Length: 920} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=24.9]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=53.9, Expect=8e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=56.6, Expect=9e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.5, Expect=3e-06]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
75. | MligTC455_14829 | 56 | 1.17 | Mlig455_053237 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.599 Region-enriched R2: 3.828/0.03404 |
SSUH2 | 1.847 | - | - | 0.871 | - | 0.976 | - | Mlig455_053237 {REF} {Length: 1420} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=156, Expect=2e-43]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=117, Expect=2e-29]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=87.4, Expect=9e-19]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
76. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
1.847 | - | - | 0.869 | - | 0.978 | - | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
77. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
1.846 | - | - | 0.894 | - | 0.952 | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
78. | MligTC455_39222 | 213 | 4.44 | Mlig455_064653, Mlig455_064686 | Neo: - Age: - Region-enriched R2: 4.317/0.00597 |
1.845 | - | - | 0.952 | - | 0.893 | - | Mlig455_064653 {REF} {Length: 2836} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.9, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=7e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_56255} {RNA1310_13407} {RNA815_38407} Mlig455_064686 {REF} {Length: 3820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.5, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_50956} {RNA1310_13407} {RNA815_38407} |
|
79. | MligTC455_19783 | 37 | 0.78 | Mlig455_022120 | Neo: - Age: - |
ACE | 1.844 | - | - | - | 0.885 | 0.959 | - | Mlig455_022120 {REF} {Length: 2567} {Pfam: Angiotensin-converting enzyme [PF01401.20, score=634.0]} {Human: ENSG00000159640, ACE, angiotensin I converting enzyme, [Score=434, Expect=6e-143]; ENSG00000264813, AC113554.1, novel transcript, [Score=432, Expect=5e-142]} {Mouse: ENSMUSG00000020681, Ace, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1, [Score=439, Expect=7e-145]} {Dmel: FBgn0012037, Ance, Angiotensin converting enzyme, [RH, Score=438, Expect=3e-146]} {Celegans: WBGene00000039, acn-1, Inactive angiotensin-converting enzyme-related protein, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_6160_0_1, dd_Smed_v6_6160_0_1, [Score=353, Expect=6e-113]} {RNA1509_47279} {RNA1310_39654} {RNA815_34873} |
80. | MligTC455_49373 | 49 | 1.03 | Mlig455_000061 | Neo: - Age: - |
ECT2 | 1.844 | - | - | 0.971 | - | 0.873 | - | Mlig455_000061 {REF} {Length: 2785} {Pfam: RhoGEF domain [PF00621.22, score=121.5]; ZIP Zinc transporter [PF02535.24, score=20.6]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=72.8, Expect=2e-13]} {Mouse: ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=72.8, Expect=1e-13]} {Dmel: FBgn0262562, CG43102, [Score=77.4, Expect=3e-15]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=58.9, Expect=2e-09]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=52.8, Expect=2e-07]} {RNA1509_60002} {RNA1310_20791, RNA1509_60002} {RNA1509_60002, RNA815_13312} |
81. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
1.843 | - | - | 0.970 | - | 0.873 | - | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
82. | MligTC455_20028 | 492 | 10.25 | Mlig455_060293, Mlig455_065638 | Neo: - Age: logFC(26M/2M)=-0.541 Region-enriched R2: 1.959/0.01794 |
LRRC55 | 1.842 | - | - | 0.886 | - | 0.956 | - | Mlig455_060293 {REF} {Length: 2403} {Pfam: Leucine rich repeat [PF13855.8, score=64.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.3]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=59.7, Expect=4e-09]; ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=58.5, Expect=6e-09]; ENSMUSG00000020105, Lrig3, leucine-rich repeats and immunoglobulin-like domains 3, [Score=57.0, Expect=4e-08]} {Dmel: FBgn0033250, CG14762, [Score=63.2, Expect=2e-10]} {RNA1509_43260} {RNA1310_15302, RNA1509_43260} {RNA1509_43260, RNA815_13279} Mlig455_065638 {REF} {Length: 2056} {Pfam: Leucine rich repeat [PF13855.8, score=62.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.6]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=61.2, Expect=1e-09]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=60.1, Expect=2e-09]} {Dmel: FBgn0033250, CG14762, [Score=62.4, Expect=5e-10]} {RNA1509_43260} {RNA1310_15302} {RNA815_13279} |
83. | MligTC455_20784 | 11 | 0.23 | Mlig455_031697 | Neo: - Age: - |
1.842 | - | - | 0.963 | - | 0.879 | - | Mlig455_031697 {REF} {Length: 1362} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=40.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.5]} {Mouse: ENSMUSG00000048376, F2r, coagulation factor II (thrombin) receptor, [Score=58.9, Expect=3e-09]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=49.7, Expect=3e-06]} {Celegans: WBGene00018728, frpr-8, FMRFamide Peptide Receptor family, [Score=77.8, Expect=2e-15]} {Smed: dd_Smed_v6_37609_0_1, dd_Smed_v6_37609_0_1, [Score=219, Expect=8e-69]} {RNA1310_74957} {RNA815_27680} | |
84. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 1.842 | - | - | 0.874 | - | 0.968 | - | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
85. | MligTC455_35436 | 244 | 5.09 | Mlig455_066072 | Neo: - Age: - Region-enriched R2: 2.834/0.01983 |
GLRA2 | 1.837 | - | - | 0.957 | - | 0.880 | - | Mlig455_066072 {REF} {Length: 4141} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=147.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.1]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=249, Expect=7e-77]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=246, Expect=1e-75]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=241, Expect=9e-74]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=240, Expect=2e-73]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=237, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=246, Expect=4e-76]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=257, Expect=5e-80]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=448, Expect=7e-155]} {RNA1509_35986} {RNA1310_23400, RNA1509_35986} {RNA1509_35986, RNA815_18122} |
86. | MligTC455_40289 | 93 | 1.94 | Mlig455_017727, Mlig455_056175 | Neo: - Age: - |
BMP1, CUBN | 1.837 | - | - | 0.960 | - | 0.877 | - | Mlig455_017727 {REF} {Length: 1202} {Pfam: CUB domain [PF00431.22, score=55.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=54.7, Expect=4e-08]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.0, Expect=3e-07]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=51.6, Expect=3e-07]; ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.4, Expect=2e-07]} {RNA1310_48745} {RNA815_23305} Mlig455_056175 {REF} {Length: 2747} {Pfam: CUB domain [PF00431.22, score=62.6]} {Human: ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.8, Expect=2e-07]; ENSG00000107611, CUBN, cubilin, [Score=51.6, Expect=4e-07]} {Mouse: ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=51.6, Expect=3e-07]; ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.0, Expect=3e-07]} {RNA1310_48745} {RNA815_23305} |
87. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
1.834 | - | - | 0.875 | - | 0.959 | - | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
88. | MligTC455_53741 | 27 | 0.57 | Mlig455_014136 | Neo: - Age: - |
POMGNT1 | 1.83 | - | - | 0.967 | - | 0.863 | - | Mlig455_014136 {REF} {Length: 2328} {Pfam: GNT-I family [PF03071.17, score=64.4]} {Human: ENSG00000085998, POMGNT1, protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), [RH, Score=212, Expect=3e-59]} {Mouse: ENSMUSG00000028700, Pomgnt1, protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase, [RH, Score=211, Expect=2e-59]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=65.5, Expect=6e-11]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=60.5, Expect=2e-09]} {Smed: dd_Smed_v6_17617_0_1, dd_Smed_v6_17617_0_1, [RH, Score=179, Expect=1e-48]} {RNA1310_40753} {RNA815_46657} |
89. | MligTC455_42963 | 247 | 5.15 | Mlig455_002825 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.597 Region-enriched R2: 5.687/0.00012 |
1.826 | - | - | 0.960 | - | 0.866 | - | Mlig455_002825 {REF} {Length: 726} {RNA1310_78982} {RNA815_41084} | |
90. | MligTC455_24844 | 70 | 1.45 | Mlig455_016641, Mlig455_035592 | Neo: - Age: - Region-enriched R4: 2.424/0.04540 |
1.824 | - | - | 0.968 | - | 0.856 | - | Mlig455_016641 {REF} {Length: 2405} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=70.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=145, Expect=5e-44]} {RNA1509_2024} {RNA1310_10624} {RNA815_8671} Mlig455_035592 {REF} {Length: 632} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=70.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=145, Expect=5e-44]} {RNA1310_10624} {RNA815_27265} |
|
91. | MligTC455_40227 | 12 | 0.26 | Mlig455_010749 | Neo: - Age: - |
GRIK2 | 1.822 | - | - | 0.964 | - | 0.858 | - | Mlig455_010749 {REF} {Length: 2895} {Pfam: Ligand-gated ion channel [PF00060.28, score=133.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.0]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=306, Expect=6e-90]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=305, Expect=4e-89]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=303, Expect=1e-88]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=306, Expect=3e-90]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=303, Expect=2e-89]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=302, Expect=3e-88]} {Dmel: FBgn0039927, CG11155, [Score=291, Expect=2e-84]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=262, Expect=8e-75]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=336, Expect=1e-100]} {RNA1310_47182} {RNA815_48326} |
92. | MligTC455_28693 | 60 | 1.26 | Mlig455_022354 | Neo: - Age: - |
1.815 | - | - | 0.958 | - | 0.857 | - | Mlig455_022354 {REF} {Length: 816} {Pfam: WSC domain [PF01822.21, score=53.0]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.1, Expect=2e-06]} {RNA1509_43359} {RNA1310_59466.1} {RNA815_19988} | |
93. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.813 | - | - | - | 0.861 | 0.952 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
94. | MligTC455_17947 | 64 | 1.34 | Mlig455_042563 | Neo: - Age: - Region-enriched R2: 7.054/0.00113 |
ASCL5 | 1.812 | - | - | 0.967 | - | 0.845 | - | Mlig455_042563 {REF} {Length: 1821} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=52.5]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=84.7, Expect=6e-20]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=84.0, Expect=5e-20]} {Dmel: FBgn0002922, nau, nautilus, [Score=49.3, Expect=6e-07]} {Celegans: WBGene00001952, hlh-6, Helix-loop-helix protein 6, [RH, Score=90.9, Expect=4e-22]} {Smed: dd_Smed_v6_14753_0_1, dd_Smed_v6_14753_0_1, [RH, Score=76.6, Expect=2e-17]} {RNA1310_71187} |
95. | MligTC455_37372 | 24 | 0.5 | Mlig455_068455 | Neo: - Age: - |
1.812 | - | - | 0.963 | - | 0.849 | - | Mlig455_068455 {REF} {Length: 2670} {RNA1310_9941.1} {RNA815_16538} | |
96. | MligTC455_41965 | 57 | 1.18 | Mlig455_002417, Mlig455_017063, Mlig455_059590 | Neo: - Age: Up-Down-Down |
GABRA6 | 1.812 | - | - | 0.973 | - | 0.839 | - | Mlig455_002417 {REF} {Length: 1761} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=82.2]} {RNA1509_50524} {RNA1310_45397} {RNA815_14584.1} Mlig455_017063 {REF} {Length: 3275} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.3]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=56.7]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=191, Expect=3e-56]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=196, Expect=4e-58]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=189, Expect=2e-55]} {Dmel: FBgn0030707, CG8916, [Score=259, Expect=3e-82]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=193, Expect=2e-57]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=234, Expect=1e-73]} {RNA1509_52113} {RNA1310_20592} {RNA815_40535} Mlig455_059590 {REF} {Length: 3109} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=102.0]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [RH, Score=296, Expect=1e-94]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [RH, Score=288, Expect=4e-90]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [RH, Score=284, Expect=7e-90]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [RH, Score=282, Expect=7e-89]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [RH, Score=307, Expect=3e-99]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [RH, Score=296, Expect=1e-94]} {Dmel: FBgn0030707, CG8916, [RH, Score=390, Expect=3e-129]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [RH, Score=302, Expect=4e-97]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=368, Expect=2e-123]} {RNA1509_52113} {RNA1310_20592} {RNA815_40535} |
97. | MligTC455_11064 | 54 | 1.12 | Mlig455_004434, Mlig455_004446 | Neo: - Age: - |
1.811 | - | - | 0.960 | - | 0.851 | - | Mlig455_004434 {REF} {Length: 532} {TRANSSPLICED} {RNA1310_102702} Mlig455_004446 {REF} {Length: 617} {TRANSSPLICED} {RNA1310_102702} |
|
98. | MligTC455_34614 | 24 | 0.5 | Mlig455_060978 | Neo: - Age: - |
1.811 | - | - | 0.969 | - | 0.842 | - | Mlig455_060978 {REF} {Length: 1770} {RNA1310_81929} | |
99. | MligTC455_39495 | 30 | 0.62 | Mlig455_037087 | Neo: - Age: - |
1.811 | - | - | 0.957 | - | 0.854 | - | Mlig455_037087 {REF} {Length: 1984} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.4]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
100. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 1.81 | - | - | 0.977 | - | 0.833 | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |